STJ

St. Jude Medical has issued a press release aimed at responding to points in the Muddy Waters report, and a Credit Suisse research report has dispelled some of the concerns.
The top analyst upgrades, downgrades and initiations seen on Thursday morning include Baidu, Boeing, Coeur Mining, Flextronics, NXP Semiconductors, Walt Disney and WebMD.
The top analyst upgrades, downgrades and initiations seen on Tuesday morning include Bats Global Markets, Eli Lilly, Gap, Hasbro, JD.com, Nike, Pfizer and SolarCity.
Stocks tanked on Friday but were indicated sharply higher on Tuesday after the three-day weekend and after China’s gross domestic product met expectations. While investors may feel that every...
Monday's top analyst upgrades, downgrades and initiations include AutoZone, Discover Financial Services, IBM, Microsoft, Twitter, Viacom and Wynn Resorts.
Thursday's top analyst upgrades, downgrades and initiations include Boeing, EMC, Hertz, Qualcomm, SanDisk, Twitter and XOMA.
Both companies announced the approval for a definitive agreement in which St. Jude Medical will acquire Thoratec in a cash transaction valued at roughly $3.4 billion.
Wednesday's top analyst upgrades, downgrades and initiations include Enphase Energy, Harley-Davidson, Salesforce.com, Tesla Motors and World Wrestling Entertainment.
Thursday's top analyst upgrades, downgrades and initiations include JetBlue Airways, Salesforce.com, Staples, Whiting Petroleum and Yelp.
Thursday's top analyst upgrades, downgrades and initiations include Barrick Gold, Facebook, Halcon Resources, Qualcomm, Synchrony Financial and Texas Instruments.
Monday's top analyst upgrades, downgrades and initiations include Apple, BP, Hewlett-Packard, Philip Morris, UnitedHealth and AT&T.
Wednesday's top analyst upgrades and downgrades include Apple, Esperion Therapeutics, MercadoLibre, Oracle and Pandora Media.
Merrill Lynch analysts have added BlackRock and retained Citigroup on the firm's prized US 1 list.
Oppenheimer has released its list of potential post-election winners in the medical device industry.
A new addition to the Merrill Lynch U.S.1 list prompted us to review their top stocks to buy, and they are not the same old monkey-see, monkey-do ideas that are so common on Wall Street.